Team:Toulouse/Result/experimental-results

From 2014.igem.org

(Difference between revisions)
Line 132: Line 132:
<p class="title2"> 1. Preliminary experiments
<p class="title2"> 1. Preliminary experiments
</p>
</p>
-
<p class="title3">Purpose
+
<p class="title3">Tests with commercial peptides and controls
</p>
</p>
-
 
+
<p class="texte">The first tests were accomplished with commercial GAFP-1 and D4E1 peptides at different concentrations (2,5µM/12,5µM/25µM/100µM). These tests were performed on different fungal strains sharing the same phylum with <i>Ceratocystis Platani</i>.</br>
-
<p class="textesimple">Tests with commercial peptides</p>
+
-
<p class="title3">Results
+
-
</p>
+
-
<p class="texte">The first tests were accomplished with commercial GAFP-1 and D4E1 peptides at different concentrations (12,5µM/25µM/100µM). These tests were performed on different fungal strains sharing the same phylum with <i>Ceratocystis Platani</i>.</br>
+
As <i>Ceratocystis Platani</i> is pathogenic, we could not perform tests directly with this fungus.</br>
As <i>Ceratocystis Platani</i> is pathogenic, we could not perform tests directly with this fungus.</br>
-
After several days at 30°C, the PDA (Potato Dextrose Agar) plates covered with fungus and commercial peptides were analyzed.
+
After several days at 30°C, the PDA (Potato Dextrose Agar) plates couvered with fungus and commercial peptides were analyzed.
 +
</p>
 +
<p class="title3">Results
</p>
</p>
-
 
</br>
</br>
FIGURE  
FIGURE  
Line 151: Line 148:
</br>
</br>
-
FIGURE
+
 
 +
<img style="width:400px; " src="https://static.igem.org/mediawiki/parts/a/a8/Prelim_tests_fung.jpg">
 +
<img style="width:400px; " src="https://static.igem.org/mediawiki/parts/f/f8/Controls_fung.jpg">
 +
 
 +
 
</br>
</br>
Line 162: Line 163:
<p class="texte">In order to test <i>Bacillus subtilis</i> mutants, it was essential to find the right balance between the fungal growth and the bacterial one. This condition was necessary to get a high concentration of peptides. In our genetic constructions, these peptides are designed to be exported in the extracellular medium.</br>
<p class="texte">In order to test <i>Bacillus subtilis</i> mutants, it was essential to find the right balance between the fungal growth and the bacterial one. This condition was necessary to get a high concentration of peptides. In our genetic constructions, these peptides are designed to be exported in the extracellular medium.</br>
</br>
</br>
-
The transformed <i>Bacillus subtilis</i> strains were grown at 37°C during 72h and tested. After centrifugation, the supernatant and the resuspended pellet were placed on pads and disposed on plates previously seeded with a defined number of conidia (see protocols to have more details). After several days at room temperature, an inhibition halo of <br><i>Trichoderma reesei</i>'s growth was clearly observable for the strain expressing D4E1 gene. The inhibition was even more noticeable with the strain carrying the operon GAFP-1 + D4E1.</br>
+
The transformed <i>Bacillus subtilis</i> strains were grown at 37°C during 72h and tested. After centrifugation, the supernatant and the resuspended pellet were placed on pads and disposed on plates previously seeded with a defined number of conidia (see protocols to have more details). After several days at room temperature, an inhibition halo of <i>Trichoderma reesei</i>'s growth was clearly observable for the strain expressing D4E1 gene. The inhibition was even more noticeable with the strain carrying the operon GAFP-1 + D4E1 (see the photos below).</br>
However, no effect was detected for the strain expressing the GAFP-1 gene, supposing a synergistic effect between these two peptides.</br>
However, no effect was detected for the strain expressing the GAFP-1 gene, supposing a synergistic effect between these two peptides.</br>
Regarding EcAMP and the triple-fungicides operon, no effect has been detected on the fungal growth. Several factors can explain these results: a number of post-transcriptional modifications are required to have a functional EcAMP and in addition to that, sequencing results of these constructs showed some differences with the original designed sequence.
Regarding EcAMP and the triple-fungicides operon, no effect has been detected on the fungal growth. Several factors can explain these results: a number of post-transcriptional modifications are required to have a functional EcAMP and in addition to that, sequencing results of these constructs showed some differences with the original designed sequence.
Line 168: Line 169:
</br>
</br>
-
PHOTO
+
<img style="width:400px; " src="https://static.igem.org/mediawiki/parts/c/c2/Resultfong.jpg">
</br>
</br>
Line 176: Line 177:
After this set of experiments, the strain expressing the operon GAFP-1 + D4E1 has shown to be the best candidate to play a major role in the fight against fungal diseases such as Canker stain. Our team decided to follow the experiments on a model plant.</br>
After this set of experiments, the strain expressing the operon GAFP-1 + D4E1 has shown to be the best candidate to play a major role in the fight against fungal diseases such as Canker stain. Our team decided to follow the experiments on a model plant.</br>
Thanks to the diversity of anti-fungal peptides, this strategy can be adapted to different types of diseases, with different degree of specifity, etc.
Thanks to the diversity of anti-fungal peptides, this strategy can be adapted to different types of diseases, with different degree of specifity, etc.
 +
 +
 +
 +
PHOTO SUR PLANTE
</p>
</p>

Revision as of 14:34, 9 October 2014